Tags

Type your tag names separated by a space and hit enter

[Clinical application of gonadotropin-releasing hormone antagonist in Chinese women undergoing controlled ovarian hyperstimulation for in vitro fertilization and embryo transfer].
Nan Fang Yi Ke Da Xue Xue Bao. 2007 May; 27(5):588-90.NF

Abstract

OBJECTIVE

To analyze the clinical characteristics and cycle outcome of Chinese women with gonadotropin-releasing hormone (GnRH) antagonist treatment during controlled ovarian hyperstimulation (COH) for in vitro fertilization and embryo transfer (IVF-ET).

METHODS

A retrospective review was conducted in patients who completed 54 consecutive cycles of IVF-ET with GnRH antagonist treatment for luteinizing hormone (LH) surge prevention. Descriptive statistics were recorded for the patients' age, GnRH treatment duration (days) and dose, timing and duration of GnRH antagonist treatment, serum E2 and LH level on the day of antagonist use and hCG injection, number of oocytes retrieved, and clinical pregnancy rate.

RESULTS

The clinical pregnancy rate was 46.2% per ET cycle for GnRH antagonist group and 56.8% in GnRH agonist group, showing no significant difference between the two protocols. The age of the patients with GnRH antagonist averaged 35.7-/+3.8 years. Gn and GnRH antagonist treatment lasted for 8.5-/+1.6 and 4.5-/+1.1 days, respectively. On the day of ovulation triggered by hCG, the serum estradiol level was 1616.7-/+721.1 pg/ml, and a mean of 7.4-/+4.6 oocytes was collected per retrieval. The number of the embryos transferred was 2.4-/+0.6, with an implantation rate of 27.7%, resulting in a clinical pregnancy rate of 50.0% in the fixed protocol (antagonist initiation on day 4 or 5 of stimulation) and 37.5% in the flexible protocol (antagonist treatment initiated for a follicle of 12-15 mm, on day 6 to 9 of stimulation).

CONCLUSIONS

GnRH antagonists treatment results in good outcomes and can be safe, short, convenient and effective for Chinese women undergoing COH for IVF. GnRH antagonist treatment can be initiated on day 4 to 9 of Gn stimulation to obtain comparable pregnancy rate.

Authors+Show Affiliations

Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China. chensl@fimmu.comNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

English Abstract
Journal Article
Research Support, Non-U.S. Gov't

Language

chi

PubMed ID

17545062

Citation

Chen, Shi-ling, et al. "[Clinical Application of Gonadotropin-releasing Hormone Antagonist in Chinese Women Undergoing Controlled Ovarian Hyperstimulation for in Vitro Fertilization and Embryo Transfer]." Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University, vol. 27, no. 5, 2007, pp. 588-90.
Chen SL, Yin MN, Sun L, et al. [Clinical application of gonadotropin-releasing hormone antagonist in Chinese women undergoing controlled ovarian hyperstimulation for in vitro fertilization and embryo transfer]. Nan Fang Yi Ke Da Xue Xue Bao. 2007;27(5):588-90.
Chen, S. L., Yin, M. N., Sun, L., Li, H., Chen, X., Song, H. D., He, J. X., Zhu, L., & Xing, F. Q. (2007). [Clinical application of gonadotropin-releasing hormone antagonist in Chinese women undergoing controlled ovarian hyperstimulation for in vitro fertilization and embryo transfer]. Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University, 27(5), 588-90.
Chen SL, et al. [Clinical Application of Gonadotropin-releasing Hormone Antagonist in Chinese Women Undergoing Controlled Ovarian Hyperstimulation for in Vitro Fertilization and Embryo Transfer]. Nan Fang Yi Ke Da Xue Xue Bao. 2007;27(5):588-90. PubMed PMID: 17545062.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Clinical application of gonadotropin-releasing hormone antagonist in Chinese women undergoing controlled ovarian hyperstimulation for in vitro fertilization and embryo transfer]. AU - Chen,Shi-ling, AU - Yin,Min-na, AU - Sun,Ling, AU - Li,Hong, AU - Chen,Xin, AU - Song,Hua-dong, AU - He,Jin-xia, AU - Zhu,Liang, AU - Xing,Fu-qi, PY - 2007/6/5/pubmed PY - 2010/8/17/medline PY - 2007/6/5/entrez SP - 588 EP - 90 JF - Nan fang yi ke da xue xue bao = Journal of Southern Medical University JO - Nan Fang Yi Ke Da Xue Xue Bao VL - 27 IS - 5 N2 - OBJECTIVE: To analyze the clinical characteristics and cycle outcome of Chinese women with gonadotropin-releasing hormone (GnRH) antagonist treatment during controlled ovarian hyperstimulation (COH) for in vitro fertilization and embryo transfer (IVF-ET). METHODS: A retrospective review was conducted in patients who completed 54 consecutive cycles of IVF-ET with GnRH antagonist treatment for luteinizing hormone (LH) surge prevention. Descriptive statistics were recorded for the patients' age, GnRH treatment duration (days) and dose, timing and duration of GnRH antagonist treatment, serum E2 and LH level on the day of antagonist use and hCG injection, number of oocytes retrieved, and clinical pregnancy rate. RESULTS: The clinical pregnancy rate was 46.2% per ET cycle for GnRH antagonist group and 56.8% in GnRH agonist group, showing no significant difference between the two protocols. The age of the patients with GnRH antagonist averaged 35.7-/+3.8 years. Gn and GnRH antagonist treatment lasted for 8.5-/+1.6 and 4.5-/+1.1 days, respectively. On the day of ovulation triggered by hCG, the serum estradiol level was 1616.7-/+721.1 pg/ml, and a mean of 7.4-/+4.6 oocytes was collected per retrieval. The number of the embryos transferred was 2.4-/+0.6, with an implantation rate of 27.7%, resulting in a clinical pregnancy rate of 50.0% in the fixed protocol (antagonist initiation on day 4 or 5 of stimulation) and 37.5% in the flexible protocol (antagonist treatment initiated for a follicle of 12-15 mm, on day 6 to 9 of stimulation). CONCLUSIONS: GnRH antagonists treatment results in good outcomes and can be safe, short, convenient and effective for Chinese women undergoing COH for IVF. GnRH antagonist treatment can be initiated on day 4 to 9 of Gn stimulation to obtain comparable pregnancy rate. SN - 1673-4254 UR - https://www.unboundmedicine.com/medline/citation/17545062/[Clinical_application_of_gonadotropin_releasing_hormone_antagonist_in_Chinese_women_undergoing_controlled_ovarian_hyperstimulation_for_in_vitro_fertilization_and_embryo_transfer]_ DB - PRIME DP - Unbound Medicine ER -